{
  "main_header": {
    "sid": 641789,
    "name": "Lupin",
    "stock_name": "Lupin",
    "full_name": "Lupin Ltd.",
    "name_url": "stocks-analysis/lupin",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,276.80",
    "chg": 3.2,
    "chgp": "0.14%",
    "dir": 1,
    "prev_price": "2,273.60",
    "mcapval": "100,152.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 500257,
    "symbol": "LUPIN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE326A01037",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "12.53 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/lupin-641789-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "641789",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/lupin-641789"
  },
  "announcements": [
    {
      "caption": "Acquisition Of Minority Shareholding In Multicare Pharmaceuticals Philippines Inc.",
      "datetime": "01-Apr-2026",
      "details": "Signing of definitive agreement for Acquisition of minority shareholding in Multicare Pharmaceuticals Philippines Inc. by Nanomi B.V. the Netherlands a wholly owned subsidiary of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
      "datetime": "01-Apr-2026",
      "details": "Update: Completion of acquisition of entire share capital of VISUfarma B.V. Netherlands by Nanomi B.V. the Netherlands wholly owned subsidiary of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "31-Mar-2026",
      "details": "Lupin Receives Tentative Approval from U.S. FDA for Sugammadex Injection.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has declared <strong>600%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>2:10</strong> stock split, ex-date: 27 Aug 10",
          "dt": "2010-08-27",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 11 Aug 06",
          "dt": "2006-08-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News